Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC miconazole promotion by Florida PruCare decreased Rx cream use by 24% in first year.

This article was originally published in The Tan Sheet

Executive Summary

OTC MICONAZOLE PROMOTION BY FLORIDA PRUCARE LED TO 24% FEWER PRESCRIPTIONS for Terazol, Ortho's Rx terconazole cream for vaginal yeast infections, during the first year, Integrated Pharmacy Solutions Divisional Pharmacy Director William Mazanec reported at a Jan. 24-26 managed care conference in Orlando, Fla. Discussing the results of the fledgling OTC support program initiated by the managed care organization in mid-1993, Mazanec also noted that the decrease in Terazol prescriptions "has sustained itself" into the second year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel